Navigation Links
CASI Pharmaceuticals Receives Approval From CFDA To Conduct Phase II Clinical Trial With ENMD-2076 For Triple-Negative Breast Cancer In China
Date:7/21/2014

with ENMD-2076 in triple-negative breast cancer, advanced/metastatic soft tissue sarcoma and advanced ovarian clear cell carcinomas.  The Company is headquartered in Rockville, Maryland and has a wholly owned subsidiary and R&D Center in Beijing, China.  Additional information about CASI is available at www.casipharmaceuticals.com and in various filings with the U.S. Securities and Exchange Commission.

Forward Looking Statements

This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act with respect to the outlook for expectations for future financial or business performance, strategies, expectations and goals.  Forward-looking statements are subject to numerous assumptions, risks and uncertainties, which change over time. Forward-looking statements speak only as of the date they are made, and no duty to update forward-looking statements is assumed.

Actual results could differ materially from those currently anticipated due to a number of factors, including: the risk that we may be unable to continue as a going concern as a result of our inability to raise sufficient capital for our operational needs; the possibility that we may be delisted from trading on the Nasdaq Capital Market; the volatility in the market price of our common stock; the difficulty of executing our business strategy in China; our inability to enter into strategic partnerships for the development, commercialization, manufacturing and distribution of our proposed product candidate or future candidates; risks relating to the need for additional capital and the uncertainty of securing additional funding on favorable terms; risks associated with our product candidates; risks associated with any early-stage products under development; the risk that results in preclinical mo
'/>"/>

SOURCE CASI Pharmaceuticals, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
2. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
3. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
4. BioElectronics Survey Indicates a Five-Fold Superior Pain Relief Compared to OTC Pharmaceuticals
5. Icahn Issues Statement Regarding Amylin Pharmaceuticals
6. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
7. Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study
8. Onyx Pharmaceuticals Announces FDA Advisory Committee to Review Carfilzomib for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma
9. Jazz Pharmaceuticals Announces First Quarter 2012 Financial Results Conference Call On May 8, 2012
10. Inovio Pharmaceuticals Granted U.S. Patent Protection for Synthetic Vaccine for Cervical Dysplasia and Cancer
11. Avanir Pharmaceuticals To Present at Three Conferences In May
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/13/2014)... 11, 2014 Research and Markets ... the "Drug Injection Devices to 2020" ... http://photos.prnewswire.com/prnh/20130307/600769 As new drugs ... list of health conditions, drug developers have increasingly ... administration process and increase the efficiency and reliability ...
(Date:12/13/2014)... , Dec. 12, 2014 HudsonAlpha ... the HiSeq X Ten sequencing system manufactured by ... HudsonAlpha to produce and analyze genomic data faster ... from the Institute,s commitment to research programs for ... HiSeq X Ten provides unprecedented capacity, speed and ...
(Date:12/13/2014)... and INDIANAPOLIS , Dec. 12, 2014 ... Chip Ganassi Racing Teams (CGRT), today announced a multi-year extension ... primary sponsor of the No. 83 Novo Nordisk Chip Ganassi ... Verizon IndyCar Series. Kimball, 29, from ... licensed driver with diabetes in the history of INDYCAR to ...
Breaking Medicine Technology:Drug Injection Devices to 2020 2Drug Injection Devices to 2020 3Drug Injection Devices to 2020 4HudsonAlpha announces purchase of Illumina HiSeq X Ten sequencing system 2HudsonAlpha announces purchase of Illumina HiSeq X Ten sequencing system 3Novo Nordisk and Chip Ganassi Racing Teams Announce Multi-Year Sponsorship Agreement for Verizon IndyCar Series 2Novo Nordisk and Chip Ganassi Racing Teams Announce Multi-Year Sponsorship Agreement for Verizon IndyCar Series 3Novo Nordisk and Chip Ganassi Racing Teams Announce Multi-Year Sponsorship Agreement for Verizon IndyCar Series 4Novo Nordisk and Chip Ganassi Racing Teams Announce Multi-Year Sponsorship Agreement for Verizon IndyCar Series 5Novo Nordisk and Chip Ganassi Racing Teams Announce Multi-Year Sponsorship Agreement for Verizon IndyCar Series 6Novo Nordisk and Chip Ganassi Racing Teams Announce Multi-Year Sponsorship Agreement for Verizon IndyCar Series 7
... 25, 2011 An interesting statistic: more than half (55%) ... having a hair transplant if celebrities or public figures were ... likely to be influenced than women (57% vs. 45%). ... have openly admitted to hair restoration, including Kevin Costner, Mel ...
... Wash., Jan. 24, 2011 Cardiac Science Corporation ... AED ) and diagnostic cardiac monitoring devices, ... Army,s Research, Development, and Engineering Command for the ... indicates the Powerheart AED G3 Pro complies with U.S. ...
Cached Medicine Technology:More and More Celebrities Are Embracing Hair Restoration 2Cardiac Science Awarded US Military Certification 2Cardiac Science Awarded US Military Certification 3Cardiac Science Awarded US Military Certification 4
(Date:12/17/2014)... Alan Mozes HealthDay Reporter ... holiday party season fast approaching, a new study reveals that ... arrests have fewer drunk drivers on their roads. The ... vigilantly are better able to deter inebriated revelers from getting ... new laws are being passed regarding drinking and driving," said ...
(Date:12/15/2014)... December 15, 2014 Veretekk.com, Inc. announced ... Ocean Avenue. JM Ocean Avenue has secured exclusive ... online automated marketing system. JM Ocean Avenue is ... merger of Ocean Avenue and JM International, with partial ... Billion per year company. , “After nearly 2 decades ...
(Date:12/15/2014)... Health Dialog, a leading provider of ... has received Patient Oriented Accreditation from the National ... Management (DM) Programs for asthma, congestive heart failure, ... and diabetes. This marks the 12th continuous year ... Management (DM) Programs, reaffirming Health Dialog’s focus and ...
(Date:12/15/2014)... December 15, 2014 Emergo Group, Inc., ... 26 countries in North and South America, Europe, the ... from industry participants for its 2015 Medical Device Industry ... to identify upcoming business and market trends as well ... The survey targets areas including:, , ...
(Date:12/15/2014)... 15, 2014 For the second year in ... “Top 30 Coffees of 2014.” Bird Rock Coffee Roasters’ Sumatra ... Zone Ethiopia at number 10. This is the first year ... Review’s selection is ranked on quality, value, and other aspects, ... 96 out of 100, and at $17.99 for 12-ounces, was ...
Breaking Medicine News(10 mins):Health News:Enforcement of Drunk Driving Laws Makes Roads Safer, Study Finds 2Health News:Enforcement of Drunk Driving Laws Makes Roads Safer, Study Finds 3Health News:JM Ocean Avenue secures the strategic advantages of Veretekk 2Health News:JM Ocean Avenue secures the strategic advantages of Veretekk 3Health News:JM Ocean Avenue secures the strategic advantages of Veretekk 4Health News:Health Dialog Receives NCQA Accreditation for Disease Management Programs 2Health News:Emergo’s Annual Survey Assessing the State of the Medical Device Industry Now Open 2Health News:Bird Rock Coffee Roasters Ranks Second and Tenth in Coffee Review’s ‘Top 30 Coffees of 2014’ 2
... New Data Shows a Comprehensive Technology Infrastructure Improves ... Calif., March 10 Two Kaiser Permanente studies ... that a comprehensive electronic health record can increase ... maintaining clinical quality and that connecting patients directly ...
... Medical Solutions recently completed the first 1,000 ... Scorpion Offshore Inc.,s ultra-premium jackup rig, Offshore ... Offshore the first drilling contractor to provide ... advanced healthcare, direct physician attention and improved ...
... new Autism specialistsCALDWELL, N.J., March 10 Caldwell College ... Innovations in Autism Treatment and Applied Behavior Analysis ... from 8:45 a.m. to 5:15 p.m. Widely recognized leaders in the ... science based approach to learning , will speak at the ...
... 10 /PRNewswire-Asia/ -- Obio Pharmaceutical Holdings Ltd,("Obio"/ "the Company") ... drug,TG21, against main strains of influenza virus (including avian ... process leading to clinical,trials for TG21 has already commenced. ... continue to engage prestigious institutions in USA and,China to ...
... are the two leading causes of chronic kidney disease, and during ... ensure that individuals have the information they need to take charge ... ... 10-- Diabetes and high blood pressure are the two leading causes ...
... has today announced that Guy,s and St Thomas, ... of the BigHand digital dictation workflow system, further ... patient care across a number of specialties. The ... award winning BigHand system within Oncology and Renal ...
Cached Medicine News:Health News:Kaiser Permanente Identifies Key Elements in Successful Health Care Information Technology Implementation 2Health News:Kaiser Permanente Identifies Key Elements in Successful Health Care Information Technology Implementation 3Health News:Kaiser Permanente Identifies Key Elements in Successful Health Care Information Technology Implementation 4Health News:Scorpion Offshore Inc. Pilot Project With InPlace Medical Solutions Sets New Standard for Offshore Medical Services 2Health News:Scorpion Offshore Inc. Pilot Project With InPlace Medical Solutions Sets New Standard for Offshore Medical Services 3Health News:Caldwell College to Host National Conference on Autism and Applied Behavior Analysis in April, Autism Awareness Month 2Health News:Caldwell College to Host National Conference on Autism and Applied Behavior Analysis in April, Autism Awareness Month 3Health News:Obio Pharmaceutical Announced New Antiviral Drug Discovery to Combat Influenza Virus 2Health News:Obio Pharmaceutical Announced New Antiviral Drug Discovery to Combat Influenza Virus 3Health News:American Kidney Fund Warns of Kidney Disease Risk Factors During Kidney Awareness Month 2Health News:American Kidney Fund Warns of Kidney Disease Risk Factors During Kidney Awareness Month 3Health News:Guy's and St Thomas' NHS Foundation Trust extends patient care benefits of BigHand Digital Dictation 2
... Throughput Sorter RSD ProVolume ... in the field of pre-sorting and ... of considerable speed but is also ... can be integrated. Secure and tight ...
... System RCS 800 closes various plastic primary and ... way. Different tube heights and diameters can be ... be used for send-outs. The integration into other ... System RSD 800 and High Throughput Sorter RSD ...
... DS 800 selectively removes closures from various sample ... towards the rack opening in one run. The ... PVT Systems like Sorting System RS 800 (optional), ... ProVolume and Aliquoting System RSD 800A. All common ...
... offers reagents to detect sequences of ... virus 1, 2 and 3; influenza ... syncytial virus A and B. ... create homebrew tests., *Analyte ...
Medicine Products: